Biontech SE 22UA-DE:XETRA

*Data is delayed | Exchange | EUR
Last | 05/03/24 CEST
86.10quote price arrow up+0.45 (+0.53%)
Volume
34,866
52 week range
78.42 - 115.95
Loading...
  • Open86.25
  • Day High87.00
  • Day Low85.10
  • Prev Close85.65
  • 52 Week High115.95
  • 52 Week High Date08/31/23
  • 52 Week Low78.42
  • 52 Week Low Date03/20/24

Key Stats

  • Market Cap20,732.06M
  • Shares Out237.73M
  • 10 Day Average Volume42,669.7
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-9.39

KEY STATS

  • Open86.25
  • Day High87.00
  • Day Low85.10
  • Prev Close85.65
  • 52 Week High115.95
  • 52 Week High Date08/31/23
  • 52 Week Low78.42
  • 52 Week Low Date03/20/24
  • Market Cap20,732.06M
  • Shares Out237.73M
  • 10 Day Average Volume42,669.7
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-9.39

RATIOS/PROFITABILITY

  • EPS (TTM)40.81
  • P/E (TTM)2.11
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date06/02/2022
  • Div Amount2.1322
  • Split Date-
  • Split Factor-

Latest On Biontech SE

 

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific...
Ugur Sahin M.D.
Chief Executive Officer, Member of the Management Board
Sierk Poetting Ph.D.
Chief Operating Officer, Member of the Management Board
Jens Holstein
Chief Financial Officer
Address
An der Goldgrube 12
Mainz
55131
Germany